SOLVONIS THERAPEUTICS PLC

Active London

Other professional, scientific and technical activities n.e.c.

6 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.
S

SOLVONIS THERAPEUTICS PLC

Other professional, scientific and technical activities n.e.c.

Founded 18 May 2017 Active London, United Kingdom 6 employees website.com
Life sciences and medical technology Other professional, scientific and technical activities n.e.c.

Previous Company Names

GRAFT POLYMER (UK) PLC 1 Jul 2021 — 10 Jan 2025
GRAFT POLYMER (UK) LIMITED 18 May 2017 — 1 Jul 2021
Accounts Submitted 1 Jun 2026 Next due 30 Jun 2026 19 days remaining
Confirmation Submitted 27 May 2025 Next due 31 May 2026 11 days overdue
Net assets £6M £3M 2025 year on year
Total assets £8M £4M 2025 year on year
Total Liabilities £1M £1M 2025 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Eccleston Yards 25 Eccleston Place London SW1W 9NF United Kingdom

Website

www.example.com

Full company profile for SOLVONIS THERAPEUTICS PLC (10776788), an active life sciences and medical technology company based in London, United Kingdom. Incorporated 18 May 2017. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2025
Type group
Next accounts 31 Dec 2025
Due by 30 Jun 2026 19 days remaining

Balance Sheet & P&L (2018–2025)

Cash in Bank

£1.72M

Increased by £963.00k (+127%)

Net Assets

£6.19M

Increased by £3.11M (+101%)

Total Liabilities

£1.39M

Increased by £1.27M (+1071%)

Turnover

N/A

Employees

6

Increased by 3 (+100%)

Debt Ratio

18%

Increased by 14 (+350%)

Financial History

Revenue, profit, EBITDA and key financial figures

2025
31 Dec Year End
2024
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 6,765,806,194 Shares £3908100009.44m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Sept 202581,732,308£106k£0.001
3 Sept 202560,142,923£180k£0.003
3 Sept 2025378,787,876£1.25m£0.003
3 Sept 202523,636,362£78k£0.003
24 Jul 202520,000,000£20k£0.001

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (20)

William Potts
23.2%
Alba Capital Pty Ltd
11.2%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Chitta Lu Limited

Ceased 6 Sept 2017

Ceased

Robert Neville Chisholm Eastman & Elizabeth Anne Eastman A/t Neville Eastman Family Trust

Ceased 6 Sept 2017

Ceased

Victor Bolduev

Ceased 4 Jan 2024

Ceased

Group Structure

Group Structure

SOLVONIS THERAPEUTICS PLC Current Company
GRAFTBIO LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
1 Jun 2026AccountsAnnual accounts made up to 31 Dec 2025
5 Jan 2026OfficersAppointment of Paul Rutherford Carter as director on 27 Oct 2025
20 Nov 2025CapitalAllotment of shares (GBP 6,806,403.493) on 7 Nov 2025
15 Oct 2025AuditorsAuditors Resignation Company
29 Jul 2025CapitalAllotment of shares (GBP 6,262,104.024) on 24 Jul 2025
1 Jun 2026 Accounts

Annual accounts made up to 31 Dec 2025

5 Jan 2026 Officers

Appointment of Paul Rutherford Carter as director on 27 Oct 2025

20 Nov 2025 Capital

Allotment of shares (GBP 6,806,403.493) on 7 Nov 2025

15 Oct 2025 Auditors

Auditors Resignation Company

29 Jul 2025 Capital

Allotment of shares (GBP 6,262,104.024) on 24 Jul 2025

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2025

1 weeks ago on 1 Jun 2026

Appointment of Paul Rutherford Carter as director on 27 Oct 2025

5 months ago on 5 Jan 2026

Allotment of shares (GBP 6,806,403.493) on 7 Nov 2025

6 months ago on 20 Nov 2025

Auditors Resignation Company

7 months ago on 15 Oct 2025

Allotment of shares (GBP 6,262,104.024) on 24 Jul 2025

10 months ago on 29 Jul 2025